Myopia Profile Sign in Sign in

Myopia control spectacles.

Spectacle lenses offer the benefits of simple, accessible vision correction, with myopia control specific designs also offering robust myopia control efficacy suitable to a wide range of patients and prescriptions.

All children with myopia require spectacles, whether for full-time wear or as a back-up to contact lens wear. Spectacle lenses for myopia control have evolved from historical research on minimally effective progressive addition and less effective bifocal lenses, to new designs which employ tiny lenslets, diffusers and other optical components applied across a single vision lens. Efficacy may vary between designs. Full-time wear of myopia control specific designs is recommended to achieve the best outcomes.

Learn more from following the links on this page.

See all myopia control products

Myopia control spectacle articles.

When to prescribe spectacles for myopia controlBinocular visionWhen to prescribe spectacles for myopia controlHere we explore an overview of spectacle prescribing for myopia management - when to use single vision, to progressive and bifocals, new designs plus more.Read full article The next generation spectacle lenses for myopia controlMyopia control efficacyThe next generation spectacle lenses for myopia controlThe newest myopia controlling spectacles can both correct and control myopia as well as contact lens options. Here we investigate.Read full article Encouraging full time spectacle wear in kidsClinical communicationEncouraging full time spectacle wear in kidsWith myopia controlling spectacles, parents may express concern for accidental breakage when playing sports. What are your recommendations?Read full article New clinical evidence on MiYOSMART: Long-term outcomes over 8 to 10 years, pre-myopia, combination treatment and 3-year outcomes in UK childrenSpectaclesPre-myopiaNew clinical evidence on MiYOSMART: Long-term outcomes over 8 to 10 years, pre-myopia, combination treatment and 3-year outcomes in UK childrenThe latest clinical research on MiYOSMART long-term outcomes and novel applications. Read full article MiYOSMART iQ: The next evolution of D.I.M.S. TechnologyMiYOSMART iQ: The next evolution of D.I.M.S. TechnologyLearn more about MiYOSMART iQ spectacle lens, HOYA's latest DIMS-based spectacle lens designRead full article Microlens spectacles delay myopia onset in pre-myopic childrenAxial lengthMicrolens spectacles delay myopia onset in pre-myopic childrenThis study found microlens spectacle lenses reduced axial elongation and delay myopia onset in pre-myopic children, with comparable efficacy across DIMS, HAL and DSDO lens designs.Read full article Introducing Essilor® Stellest® 2.0 lenses - Q&A with Dr. Björn DrobeSpectaclesGlassesIntroducing Essilor® Stellest® 2.0 lenses - Q&A with Dr. Björn DrobeWe talk to Dr Björn Drobe about the research behind the Essilor® Stellest® 2.0 lens.‡ Read full article EssilorLuxottica at ARVO 2026: key insights in myopia researchSpectaclesPre-myopiaEssilorLuxottica at ARVO 2026: key insights in myopia researchEssilorLuxottica brought new research advancements to ARVO 2026 on Essilor® Stellest® lenses and more. Here's what clinicians need to know.Read full article ARVO2026 Recap #4 – Can we prevent myopia in children & treat it in adults?Pre-myopiaAtropineARVO2026 Recap #4 – Can we prevent myopia in children & treat it in adults?The fourth recap from ARVO 2026 explores the strategies for myopia prevention in young children and evidence on myopia treatment options in adults.Read full article ARVO2026 Recap #3 – New and improved lens designs & combination therapyCombination treatmentARVO2026 Recap #3 – New and improved lens designs & combination therapyThe third recap from ARVO 2026 highlights next-generation myopia control lens designs and modern approaches to combination therapy.Read full article ARVO2026 Recap #2 – Spectacle lenses under the spotlightSpectaclesARVO2026 Recap #2 – Spectacle lenses under the spotlightThe second recap from ARVO 2026 is all about the latest evidence on spectacle lenses, including Stellest, DOT, MyoCare, and MyCon designs.Read full article Seasonal efficacy variation in ortho-k and defocus spectaclesClinical communicationSeasonal efficacy variation in ortho-k and defocus spectaclesStudy finds winter doubles axial elongation versus summer in children using ortho-k or atropine with defocus spectacles.Read full article Understanding the current evidence for myopia control methodsAxial lengthUnderstanding the current evidence for myopia control methodsA 2026 overview of research on childhood myopia control, including optical, pharmacological and behavioural approaches shown to slow eye growth.Read full article Novel multiregion spectacle lenses versus HAL for myopia controlAxial lengthNovel multiregion spectacle lenses versus HAL for myopia controlOne-year trial comparing Grid Dimension Multiregion (GDM) and HAL myopia control spectacles shows borderline axial length benefit and reduced efficacy over time.Read full article DIMS plus atropine vs ortho-k for myopia controlAxial lengthDIMS plus atropine vs ortho-k for myopia controlA one-year real-world study found DIMS spectacles with 0.01% atropine produced marginally less axial elongation than ortho-k in children with myopia.Read full article ASPECT trial finds 0.025% atropine and DIMS lenses slow axial lengthAxial lengthASPECT trial finds 0.025% atropine and DIMS lenses slow axial length This randomised controlled trial found that 0.025% atropine with DIMS lenses slowed axial length growth more than 0.025% atropine with standard spectacles Read full article Dropout rates among optical interventions for myopia control: a systematic review Soft contact lensesOrtho-kDropout rates among optical interventions for myopia control: a systematic review This systematic review compares dropout rates across spectacle, soft contact lens, and ortho-k interventions in paediatric myopia control clinical trials.Read full article Myopic children with intermittent exotropia adapt well to StellestBinocular visionMyopic children with intermittent exotropia adapt well to StellestStellest lenses have minimal effects on binocular vision in myopic children, including those with intermittent exotropia.Read full article Essilor Stellest lenses receive FDA market authorization in the U.S.SpectaclesEssilor Stellest lenses receive FDA market authorization in the U.S.Essilor® Stellest® lenses have received FDA market authorization in the U.S., marking an important milestone for expanding access to spectacle-based myopia management for children.Read full article Atropine 0.01% and 0.125% similarly boost DIMS efficacyCombination treatmentAtropine 0.01% and 0.125% similarly boost DIMS efficacyDIMS lenses combined with atropine slowed myopia progression more effectively than DIMS alone, regardless of high (0.125%) or low (0.01%) atropine concentration.Read full article Three key myopia questions for 2026 Light therapiesAtropineThree key myopia questions for 2026 Atropine 0.01% monotherapy, second generation spectacle lenses and light therapy combo treatments - much to learn!Read full article CARE spectacle lenses slow myopia over 2 yearsMyopia control efficacyCARE spectacle lenses slow myopia over 2 yearsCARE lenses slowed myopia by up to 0.44 D and 0.20 mm over 2 years in Chinese children, with sustained efficacy through year two.Read full article Boosted asphericity improves efficacy of Essilor Stellest designSpectaclesBoosted asphericity improves efficacy of Essilor Stellest designH.A.L.T. MAX lenses with increased lenslet asphericity slowed eye growth by 0.107 mm more than standard Stellest lenses over 12 months.Read full article The impact of rebound in myopia controlAxial lengthThe impact of rebound in myopia controlRebound can be miscalculated in myopia control. This review explains the correct approach and finds minimal rebound for optical treatments, but more for pharmacological ones.Read full article HALT lenses with low dose atropine slow myopia progressionSoft contact lensesSpectaclesHALT lenses with low dose atropine slow myopia progressionChildren progressing on low-dose atropine showed reduced axial elongation and refractive change after HALT lenses were added to their treatment.Read full article Defocus lenslet spectacles leave accommodation unchangedMechanismsBinocular visionDefocus lenslet spectacles leave accommodation unchangedStable accommodation with myopia control spectacle lenses suggests other mechanisms drive treatment effects of peripheral opticsRead full article Microlens spectacles reduce myopia progression in childrenSelecting a treatment strategyMicrolens spectacles reduce myopia progression in childrenThis meta-analysis found microlens designs more effective for myopia control than non-microlens or single vision lenses in children.Read full article Comparing the rebound effects of myopia control interventionsSoft contact lensesComparing the rebound effects of myopia control interventionsThis review compared rebound effects among different myopia control treatments, finding less rebound with optical options than atropine or light therapies.Read full article Asymmetric myopic peripheral defocus lenses slow myopiaSpectaclesAsymmetric myopic peripheral defocus lenses slow myopiaAsymmetric myopic peripheral defocus lenses (MPDL) reduce axial elongation in Spanish children over 2 years.Read full article Essilor Stellest lenses effective for pre-myopia with adequate wearPre-myopiaSpectaclesEssilor Stellest lenses effective for pre-myopia with adequate wearEssilor Stellest lenses reduced axial elongation and slowed refractive change in non-myopic Chinese children.Read full article 

Myopia control spectacle treatments.

Myopia management products

Myopia management products listed by Myopia Profile have been specifically designed for myopia control or myopia management in children, and have some form of regulatory approval or marking for this form of use. They also have randomized controlled trial research data supporting their efficacy, unless otherwise noted. It is up to the individual eye care practitioner to be aware of regulatory requirements for prescribing in their country of practice, and also be aware that not all products are available in all countries. Essilor® Stellest® lens.jpgEssilor® Stellest®Stellest 2.0-2.jpgEssilor® Stellest® 2.0 lensesmiyosmart_2.pngMiYOSMARTmiyosmartiqcropped.jpgMiYOSMART iQstacks-image-46c9ceb.jpgMyopilux MaxSightglass-final.pngSightGlass Vision DOTmyocare-pov.jpgMyoCare

Enormous thanks to our visionary sponsors

Myopia Profile’s growth into a world leading platform has been made possible through the support of our visionary sponsors, who share our mission to improve children’s vision care worldwide. Click on their logos to learn about how these companies are innovating and developing resources with us to support you in managing your patients with myopia.